Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart.

× No keyword cloud information.

26 in total

1. A community consultation survey to evaluate support for and success of the IMMEDIATE trial.

Authors: Joni R Beshansky; Patricia R Sheehan; Kenneth J Klima; Nira Hadar; Ellen M Vickery; Harry P Selker
Journal: Clin Trials Date: 2014-04 Impact factor: 2.486

2. The gut hormone ghrelin partially reverses energy substrate metabolic alterations in the failing heart.

Authors: Gianfranco Mitacchione; Jeffrey C Powers; Gino Grifoni; Felix Woitek; Amy Lam; Lien Ly; Fabio Settanni; Catherine A Makarewich; Ryan McCormick; Letizia Trovato; Steven R Houser; Riccarda Granata; Fabio A Recchia
Journal: Circ Heart Fail Date: 2014-05-22 Impact factor: 8.790

3. Usefulness of serum unbound free fatty acid levels to predict death early in patients with ST-segment elevation myocardial infarction (from the Thrombolysis In Myocardial Infarction [TIMI] II trial).

Authors: Andrew H Huber; J Patrick Kampf; Thomas Kwan; Baolong Zhu; Jesse Adams; Alan M Kleinfeld
Journal: Am J Cardiol Date: 2013-10-05 Impact factor: 2.778

4. EFFICACY-TO-EFFECTIVENESS CLINICAL TRIALS.

Authors: Harry P Selker; Sheeona Gorman; Kenneth I Kaitin
Journal: Trans Am Clin Climatol Assoc Date: 2018

5. Dietary fat is a key determinant in balancing mitochondrial dynamics in heart failure: a novel mechanism underlying the obesity paradox.

Authors: Matteo De Rosa; Jessica Gambardella; Jun Shu; Gaetano Santulli
Journal: Cardiovasc Res Date: 2018-06-01 Impact factor: 10.787

6. One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial).

Authors: Harry P Selker; James E Udelson; Joseph M Massaro; Robin Ruthazer; Ralph B D'Agostino; John L Griffith; Patricia R Sheehan; Patrice Desvigne-Nickens; Yves Rosenberg; Xin Tian; Ellen M Vickery; James M Atkins; Tom P Aufderheide; Assaad J Sayah; Ronald G Pirrallo; Michael K Levy; Michael E Richards; Darren A Braude; Delanor D Doyle; Ralph J Frascone; Donald J Kosiak; James M Leaming; Carin M Van Gelder; Gert-Paul Walter; Marvin A Wayne; Robert H Woolard; Joni R Beshansky
Journal: Am J Cardiol Date: 2014-03-01 Impact factor: 2.778

7. Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: the IMMEDIATE trial.

Authors: K L Ellis; Y Zhou; J R Beshansky; E Ainehsazan; Y Yang; H P Selker; G S Huggins; L A Cupples; I Peter
Journal: Pharmacogenomics J Date: 2014-08-19 Impact factor: 3.550

8. Genetic modifiers of response to glucose-insulin-potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial.

Authors: K L Ellis; Y Zhou; J R Beshansky; E Ainehsazan; H P Selker; L A Cupples; G S Huggins; I Peter
Journal: Pharmacogenomics J Date: 2015-03-17 Impact factor: 3.550

9. Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE Trial.

Authors: Harry P Selker; William S Harris; Charles E Rackley; Julian B Marsh; Robin Ruthazer; Joni R Beshansky; Eric J Rashba; Inga Peter; Lionel H Opie
Journal: Am Heart J Date: 2016-06-02 Impact factor: 4.749

10. Mitochondrially targeted nitro-linoleate: a new tool for the study of cardioprotection.

Authors: Sergiy M Nadtochiy; Jerry Madukwe; Fred Hagen; Paul S Brookes
Journal: Br J Pharmacol Date: 2014-04 Impact factor: 8.739